Device Trial Radar · NCT05611099
Robustness and Usability of the Dreem 3 System for at Home Sleep Monitoring in an Insomnia Population.
Last checked: Nov 20, 2026Latest source record: Nov 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Aug 15, 2022
Primary completion
Oct 31, 2022
Study completion Nov 5, 2022
Sponsor
- Lead sponsor
- DreemNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 9, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
There is an unmet medical need for monitoring sleep for multiple nights in a patient's home, without the inconvenience of traveling and staying overnight in a medical center, and without the need for a technician to set up a polysomnography (PSG) device at the patient's home. Several disorders, and particularly sleep disorders, are associated with insomnia symptoms, and longitudinal sleep assessment may support a better understanding and management of these patients, who currently seldom access sleep lab PSG. On one hand, this study aims at demonstrating whether the final device's user interface supports safe and effective use when being used at home over multiple nights. On the other, the study aims at confirming that stable and consistent data are measured in the device's actual use, for the records to be clinically usable in daily practice.
Conditions
- Insomnia, Secondary
- Sleep Disturbance
- Sleep
- Sleep Initiation and Maintenance Disorders
Interventions
Dreem 3 System vs WatchPAT OneDevice
Dreem 3 System and WatchPAT One will be worn simultaneously during 3 nights by each study participant, in order to compare the TST automatically outputted by both devices.
Usability QuestionnaireOther
After having undergone the 3 nights of measurement, an end of Study Questionnaire will be performed on a separate day to obtain Usability feedback from participants who have undergone simultaneous recordings with the Dreem 3 + WatchPAT devices.
Primary outcomes
What the sponsor says the trial is designed to measure.
- TST CorrelationTime frame: 3 nights
- Dreem 3 System usabilityTime frame: 1 day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dreem Health
Encinitas, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.